New Users Registration  |  Useful Links  |  FAQ  |  Site Map 
 
Go Search

 

Skip Navigation LinksHealth Xchange > News
  News  
  Categories  
     
  Chronology  
 
  2013 2014   Dec 2014 | Nov 2014 | Oct 2014 | Sep 2014 | Aug 2014 | Jul 2014 | Jun 2014 | May 2014 | Apr 2014 | Mar 2014 | Feb 2014 | Jan 2014 |
  2013   Dec 2013 | Nov 2013 | Oct 2013 | Sep 2013 | Aug 2013 | Jul 2013 | Jun 2013 | May 2013 | Apr 2013 | Mar 2013 | Feb 2013 | Jan 2013 |
  2012   Dec 2012 | Nov 2012 | Oct 2012 | Sep 2012 | Aug 2012 | Jul 2012Jun 2012May 2012Apr 2012Mar 2012 | Feb 2012 | Jan 2012 |
  2011   Dec 2011Nov 2011Oct 2011 | Sep 2011 | Aug 2011Jul 2011Jun 2011 | May 2011 | Apr 2011 | Mar 2011 | Feb 2011 | Jan 2011 |
  2010   Dec 2010 | Nov 2010 | Oct 2010 | Sep 2010 | Aug 2010 | Jul 2010 | Jun 2010 | May 2010 | Apr 2010 | Mar 2010 | Feb 2010 | Jan 2010 |
  2009   Dec 2009 | Nov 2009 | Oct 2009 | Sep 2009 | Aug 2009 |
 
     
  Topic  
 
  Health Policy and Announcements | Diseases and Outbreaks
  Medical Research | New Treatments and Technology
   
 
     
  RSS  
 
  Singapore   SingHealth | Health Promotion Board | Ministry of Health | Asiaone
  International   World Health Organization | Centre for Disease Control and Prevention (US)
       
 
     
  News Article  
 

Genes determine drug dosage

 
  Thursday, 05 l 05 l 2011  Source:  Mind Your Body; The Straits Times   
By: Lee Hui Chieh
     
 

Genetic tests can help doctors decide how much of a drug to give. For instance, in 2007, the United States Food and Drug Administration required a label on warfarin, stating that users of this blood-thinning drug may respond differently to it depending on their genetic make-up. This is the result of work done by researchers at National University Cancer Institute, Singapore, who found that depending on which variants of two genes they have, people on warfarin need either a higher or lower dose.

One of the genes determines how well the body can metabolise warfarin, while the other – the one inhibited by warfarin – produces a substance that makes blood clot, said Dr Lee Soo Chin, one of the researchers and a senior consultant at the institute’s department of haematology-oncology. Not enough warfarin in patients who have had a heart attack, stroke or deep vein thrombosis could mean the risk of another blood clot and a repeat attack. But an overdose could cause bleeding, which could kill.

The team has devised a formula that calculates how much warfarin a patient needs, based on his weight, age and variants of the two genes. It is now conducting a study on 320 patients to compare the success of warfarin treatment in those whose dosages were calculated using the formula and those who got doses based on the conventional trial-and-error way.

Another researcher, Dr Goh Boon Cher, who heads the institute’s haematology-oncology department, said of the formula: “This would be a safer way of prescribing medication. If this works, in future, we could be using such tests for other drugs.” In fact, other researchers here are working on this. A National Cancer Centre Singapore team, led by Associate Professor Balram Chowbay, found that people with variants of a particular gene that are more common here than in Western countries had trouble breaking down the toxic by-product of a chemotherapy drug for colorectal and stomach cancer. In these people, the by-product accumulates, causing severe diarrhoea and lowering the count of infection-beating white blood cells. They need a lower dose of the drug irinotecan than the standard dose recommended for Caucasians, said Prof Balram.

The finding led the Health Sciences Authority to update the drug’s insert last year to recommend that a genetic test be done to check for variants of the gene before the drug is prescribed. The team is conducting a study to find the dosages for those with the variant genes.

     
  Ask the Specialists - Free Doctor Q&A
(Now - 30 Apr)
 
    Feet Problems
If you have questions related to feet problems, take this opportunity to get valuable advice from a podiatrist -- now!
 
    Previous Q&As
Check out our archive for all our previous doctor's Q&As!
*Latest Update: Age-related Eye Conditions (Cataract, Glaucoma, Diabetic Retinopathy), All About Medication
 
  Medical Expertise Contributed by:  
  Singapore General Hospital
Tel: (65) 6222 3322
 
  KK Women's and Children's Hospital
Tel:(65) 6225 5554
 
  National Cancer Centre Singapore
Tel: (65) 6436 8000
 
  National Heart Centre Singapore
Tel: (65) 6436 7800
 
  Singapore National Eye Centre
Tel: (65) 6227 7255
 
  National Dental Centre Singapore
Tel: (65) 6324 8910
 
  National Neuroscience Institute
Tel: (65) 6357 7153
 
SingHealth Polyclinics
Tel: (65) 6236 4800